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skin disorders
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Seyed Ali Mousavi Shaegh1,2,6, Elmira Arab-Tehrany7,
Nasim Annabi1,2,8, Patrizia Perego3, Ali Khademhosseini1,2,9,10
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Abstract
Traditional wound dressings are not effective enough to regulate the moisture content and remove excessive exudate
from the environment. Wet wound dressings formed from hydrogels such as alginate are widely used in clinical practice
for treatment of skin disorders. Here, we functionalize alginate dressings with natural antioxidants such as curcumin and
t-resveratrol to render them both anti-inflammatory and antibacterial. The hydrogel maintains excellent mechanical
properties and oxygen permeability over time. The release rate of the compounds from the hydrogels is assessed and
their impact on bacterial and cellular growth is evaluated. The antioxidant compounds act as bactericidal agents and
improve cell viability. The optimal concentration of active compounds in the engineered alginate-based dressings
is determined.
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Introduction
Skin disorders are common and affect millions of
people worldwide. Chronic wounds are among the
most challenging skin disorders that do not heal in an
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orderly or timely manner (generally, such wounds
should heal in less than three months).1,2 Examples of
chronic wounds include burns and ulcers, which are
typically prone to infections.3 Simple infection charac-
terized by redness around the wound area can be easily
treated, but in more complicated cases it can develop
into more invasive infection and sepsis, which are more
severe and life threatening and burden the health-
care system.4,5
Traditionally, wound dressings such as natural or
synthetic bandages, cotton wool, lint and gauzes are
used for wound management. Their primary function
is to keep the wound dry and protected by allowing
evaporation of wound exudates and preventing bacte-
rial infection. However, it has been shown that main-
taining the moisture in the wound environment
accelerates the healing process.6–8 Chronic wounds gen-
erate an exudate composed of a combination of growth
factors and enzymes which aggravate the wound con-
dition and should be removed efficiently to facilitate
the healing process.9 Therefore, it is essential to have
a dressing which maintains an appropriate level of
moisture while removing excessive exudate from the
environment.10 Hydrocolloids, alginate-based sponges
and hydrogels have shown a great potential for man-
aging the liquid content in the wound environment and
have found significant applications in engineering
advanced wound dressings.11–15
Hydrogels can be used as matrices to encapsulate
active molecules, antibacterial agents and growth fac-
tors and provide a controlled release of these agents to
prevent infections and promote the healing process.15–
22 Commercial hydrogel dressings usually last about
one day before they dry out and need to be replaced.
In addition, since commercial hydrogels act as a barrier
preventing water evaporation from the wound, the use
of these hydrogels might involve the risk of limiting
oxygen access to the wound. Thus, the development
of hydrogel dressings that remain flexible and breath-
able over time represents a challenge in
wound management.
Another important function of wound dressings is
inhibiting the growth of bacteria such as
Staphylococcus aureus or Staphylococcus epidermidis,
which are part of the skin flora and are commonly
present in infected wounds.23 This process has been
so far achieved by the incorporation of antibiotics
and antibacterial compounds such as silver as well as
hyperbaric oxygen therapy.24,25 Nanoparticles of silver
(Ag) and zinc oxide (ZnO) with promising antimicro-
bial activity has been synthesized using environment-
friendly and inexpensive process and they were success-
fully incorporated into antimicrobial bandages.26,28
Silver salts have shown a great potential for preventing
bacterial growth; however, they can significantly reduce
cellular growth and the healing rate at certain concen-
trations. Antibiotics that are also widely used to
combat infections, if extensively used, may result in
the formation of new drug-resistant pathogens.29
Thus, the identification of a natural compound that
can prevent bacterial growth without affecting wound
healing and creating resistance in pathogens is of
utmost importance.
Herbal drugs with antibacterial properties are safe,
cheap and well-tolerated substitutes of those allopathic
drugs.29 For example, kaempferol and crocin were
extracted from saffron crocus (Crocus sativus L)
petals and were incorporated into two sets of biocom-
patible synthetic polymers, i.e. polyvinyl pyrrolidone
and poly ethylene glycol, and agar polysaccharide for
jellification.30 These functionalized hydrogels showed
good biocompatibility with in vitro cultured fibroblasts.
Recently, natural antioxidants such as curcumin and t-
resveratrol have been studied for their anti-
inflammatory and antibacterial activities.31–35
However, despite the recent advancements, wound
management is still a challenging area particularly
because of the complexity of the wound-healing pro-
cess as well as patient variability.
Here, we develop an alginate-based hydrogel patch
loaded with natural antioxidant compounds (curcumin
and t-resveratrol). The hydrogel maintains excellent
mechanical properties and oxygen permeability over
time. While the antioxidant compounds act as bacteri-
cidal agents and improve cell proliferation. The hydro-
gels mechanical properties, as well as oxygen
permeability and biocompatibility, are studied. The
release profile of antioxidants, their cytotoxicity, bac-
tericidal activity and in vitro wound healing properties
were also assessed (Figure 1(a)). Results confirm that
the developed hydrogel patch represents a new poten-
tial solution in the treatment of inflamed or
infected wounds.
Experimental section
Materials
Alginic acid sodium salt from brown algae (Cat:
A2033), glycerol, t-resveratrol, curcumin, calcium chlo-
ride (CaCl2), low gelling temperature agarose, acetic
acid, methanol and acetonitrile (all HPLC grade)
were purchased from Sigma-Aldrich (St. Louis, MO,
USA). PrestoBlue Cell Viability Reagent was pur-
chased from Life Technologies (California, USA).
Dulbecco’s Modified Eagle Medium (DMEM), fetal
bovine serum (FBS), 0.05% Trypsin-EDTA (1X) and
antibiotics Penicillin/Streptomycin (Pen/Strep) were
purchased from Invitrogen (Carlsbad, CA, USA).
Commercially available alginate-based patch (CVS
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Health Sterile Hydrogel Burn Pads 4 Ct, 1.96 in 2.95
in) was purchased from CVS pharmacy (Boston,
MA, USA).
Hydrogel preparation
Alginate-based hydrogels were fabricated with different
concentrations of glycerol. Briefly, sodium alginate was
dissolved in deionized water (DI) in order to prepare a
stock solution with a concentration equal to 5% (w/v),
stored at 4C. Then, the stock solution was diluted with
water and glycerol in order to produce a 2% (w/v)
solution of alginate. Alginate hydrogels are flexible
materials, but they are prone to rapid dehydration
that may lead to a brittle material. To overcome this
issue, glycerol with hygroscopic properties was added
to alginate to enhance the mechanical properties of the
hydrogel. Four different solutions were prepared: 2%
(w/v) of Na-alginate, 2% (w/v) of Na-alginate with
20% (v/v) of glycerol, 2% (w/v) of Na-alginate with
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Figure 1. Hydrogel wound dressing for local delivery of antioxidant and antimicrobial compounds and mechanical characterization.
(a) Concept of the project and its application as wound dressing. (b) A representative image of the alginate hydrogel with honeycomb
structure, with the related magnification of the microchannels to facilitate air access to cells. (c) Mechanical properties of different
hydrogel samples. Freshly-made samples and samples after 72 h dehydration at 37C were compared (****p< 0.0001). (d) Images
showing the visual appearance and resistance of the 2% (w/v) alginate with 20% (v/v) of glycerol hydrogel after 72 h at 37C under (i)
bending and (ii) twisting (scale bar: 10 mm).
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40% (v/v) of glycerol and 2% (w/v) of Na-alginate with
60% (v/v) of glycerol.
To crosslink and form the alginate hydrogels, an
aqueous solution of 2% (w/v) calcium chloride
(CaCl2) and 2% (w/v) agarose was poured in to a
PDMS flat or grooved mold and left at room temper-
ature for 30 min to solidify. The alginate solutions were
poured into another PDMS mold and the agarose gel
containing CaCl2 was used to cover the solution for 30
min to allow calcium diffusion and crosslinking of algi-
nate sheets. The grooved molds would enable the fab-
rication of channeled hydrogel dressing, which can
facilitate oxygen and exudates management.
Drug-embedded hydrogels were prepared by adding
a small amount of ethanolic solution of t-resveratrol
and curcumin in order to reach a specific concentra-
tion. Specifically, two different concentrations were
assessed for both compounds: 150 and 300 lg/mL.
Concentrations of t-resveratrol and curcumin were
chosen according to a literature review, based on the
minimum concentration that is active against
bacteria.36,37
Mechanical characterization
The mechanical properties of the hydrogels were mea-
sured at room temperature using an Instron 5542
mechanical tester (Norwood, MA, USA) with a 1-kN
load cell following the method used to measure the
mechanical properties of GelMA and other hydro-
gels.38,39 Briefly, samples were glued to two clamps to
avoid slipping and stretched up to final rupture.
Hydrogel samples were tested at a strain rate of
1mm/min. The Young’s modulus was determined as
the slope of the linear region of the stress–strain
curve corresponding to 10% strain. Mechanical prop-
erties of a commercially available alginate-based
hydrogel were also characterized by tensile stress–
strain measurement.
Water uptake
To evaluate the performance of managing the exudate,
the water uptake capacity of different alginate-with-
glycerol hydrogels was measured. Samples were
immersed in Dulbecco’s phosphate-buffered saline
(DPBS) for 3h and kept at 37C. After removing the
excess surface water, the swollen weight of each hydro-
gel was recorded. The water uptake was calculated as
the ratio of the wet mass after 3 h to the initial mass.
Oxygen permeability
To evaluate the breathability and the oxygen perme-
ation through the hydrogels, we designed and set up
a cylindrical sealed chamber, with an inlet for the
nitrogen flow and an outlet valve to remove air from
the chamber. On the opposite side, the sample’s spot
was designed as a two-rings structure, between which
the sample was placed. Oxygen concentration was
monitored using a Neofox in-situ oxygen monitoring
kit with probe (Ocean Optics). After placing the sample
in position, nitrogen was purged inside the changer
until the oxygen concentration was equal to 0%.
Then, nitrogen flow was stopped and the outlet valve
was closed. A circular window (Ø¼ 35.7mm) allowed
the permeation of the atmospheric air into the chamber
only through the sample. The variation of the oxygen
concentration was monitored over 15 min.
Different alginate-glycerol hydrogels and a commer-
cially available alginate-based hydrogel were tested. A
PDMS sheet was also tested as reference, since it is
known as a gas-permeable material. All the samples
had the same thickness (1mm).
Release studies
To check the release of biologically active compounds
to the wound area, we carried out a release study using
a model with air-liquid interface (ALI) in order to
mimic the real conditions of loaded drug release on
the wound area. t-Resveratrol and curcumin were
chosen as biologically active compounds. Several stud-
ies have shown their activity as antioxidant, anti-
inflammatory and antibacterial compounds.40
Following the procedure available in the literature, a
small amount of ethanolic solution of the compounds
was added to the solution of alginate with 20% of glyc-
erol before the crosslinking step, in order to have a
drug concentration equal to 150 and 300 lg/mL.
Samples were placed on the ALI and release profile
evaluation was performed using DPBS with 10% of
ethanol (total volume 5mL) in an incubator at 37C.
At specific time points, an aliquot of the solvent
(500 lL) was withdrawn, frozen at –20C and then
freeze-dried. Samples were then dissolved using a
small volume of ethanol and analyzed by HPLC-
DAD (Hewlett Packard 1100 Series, CA, USA)
equipped with a C18 reverse phase column (Vydac
201TP54, CA, USA) following the method described
by Aliakbarian et al.40
Antibacterial evaluation
To evaluate the antibacterial activity, disk diffusion
test was assessed using drug-embedded hydrogels with
20% (v/v) of glycerol. Staphylococcus aureus which is a
Gram-positive strain and the most frequent bacteria
found in infected wounds was used in the experiments.
Samples were cut into circular disc (6mm of diameter,
1mm of thickness) and normal 2% (w/v) alginate with
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20% (v/v) glycerol was used as control. Samples were
placed on mannitol salt agar plate and then incubated
at 37C for 24 h. If the concentration of drug was
enough to reach the inhibition, a clear disk could be
observed around the sample, meaning that bacteria
were not able to grow or were killed in that zone.
Cell studies
Human keratinocytes were maintained in Dulbecco’s
Modified Eagle Medium (DMEM, Life Technologies)
supplemented with 10% FBS and 1% Pen/Strep. Cells
were culture in a 5% CO2 atmosphere at 37
C. Cells
were passaged approximately once per week and media
was exchanged every 2 days. Cells were used after
80% confluency.
To assess the cytotoxicity or any negative impact of
the hydrogel dressings on wound closure, cell viability
tests were performed on human keratinocytes, which are
key cells in the process of wound healing. For this study,
2% (w/v) alginate hydrogels with different concentra-
tions of glycerol (13.4mm 4.3mm 1.5mm
LWT) were prepared. For drug-embedded hydro-
gels, a small amount of t-resveratrol and curcumin was
added in order to have a concentration of drug equal to
150 and 300lg/mL. Before crosslinking the alginate, all
the solutions were filtered with sterile filters under bio-
logical hood (porosity: 0.22 lm). HaCaTs were then
seeded with a cell density of 50 103 cells/mL.
Samples were incubated in a 5% CO2 atmosphere at
37C and the media was changed every 24 h. Cellular
metabolic activity was evaluated by PrestoBlue assay
according to manufacturer protocol. The blue stain
PrestoBlue reagent was uptaken by viable cells and
reduced to a fluorescing stain. The extent of reduction
is directly proportional to the cells’ metabolic activity.
The assay was performed on days 1, 3 and 7 and the
fluorescent intensity was measured using a BioTek UV/
vis Synnergy 2 microplate reader. HaCats with the same
cell density and without hydrogels were seeded and their
metabolic activity were evaluated as positive blank.
To evaluate any influence of the hydrogels on cells’
morphology, cells were fixed after 7 days and stained
with F–Actin and DAPI to visualize actin filaments
and cell nuclei, respectively. Pictures were taken using
a Zeiss Axio observer D1 microscope.
For the scratch assay, keratinocytes were cultured in
24-well plates until a confluent cell layer was formed.
Then a 100-lm scratch was formed using a pipette tip
and drug-embedded hydrogels were placed inside cul-
ture inserts (pore size of 8 lm). Microscopic images
taken over a period of 24 h to identify the migration
rate of keratinocytes were analyzed using ImageJ soft-
ware. The coverage percentage was evaluated by
measuring the scratch surface directly after scratching
and after 24 h.
Statistical analysis
Data are presented as mean standard deviation (SD).
Statistical analysis was performed using GraphPad
Prism 6 (San Diego, USA). Data were analyzed using
one- and two-ways ANOVA multiple comparison.
Statistically significant values are presented as
*p< 0.05, **p< 0.01, ***p< 0.001 and ****p< 0.0001.
Results
Alginate-based hydrogels were fabricated by crosslink-
ing a mixture of 2% Na-alginate and glycerol using a
flat sheet of agarose gel (2% w/v) containing CaCl2
(2% w/v). The Na-alginate was crosslinked through
exchanging Naþ with Ca2
þ forming a hydrophilic net-
work of calcium alginate (Figure S1). Samples were
then washed with deionized water to remove the
excess of uncrosslinked polymer. This production pro-
cess allowed the formation of hydrogel with a well-
defined structure. Following the same procedure, we
were also able to fabricate alginate patch with a high-
resolution honeycomb structure. Microchannels pre-
sented on the hydrogel surface are able to guarantee
a higher air and oxygen supply to the skin surface
(Figure 1(b)).
Alginate hydrogels are flexible materials, but they
are prone to rapid dehydration, rendering them brittle.
For this reason, glycerol, which is a hygroscopic mol-
ecule and resist evaporation at room temperature, was
added to alginate. The effect of different concentra-
tions of glycerol (0–60%) on the mechanical and han-
dling properties was assessed (Figure 1(c and d)).
Properties of the obtained hydrogels were compared
to a commercially available alginate-based patch
(CVS Health Sterile Hydrogel Burn Pads 4 Ct, 1.96
in 2.95 in). To investigate the lifetime of the engi-
neered patch and simulate its operating condition, the
samples were kept at 37C for 72 h. The results showed
that glycerol had no significant effect on the mechani-
cal properties of fresh hydrogels, but its contribution
became significant when the hydrogel was dried at 37C
for 72 h. After 24 h, the commercial alginate patch, as
well as pristine alginate sample, was brittle and fully
dried and, thus, could not withstand the tensile load-
ing. Conversely, glycerol-containing hydrogels dis-
played improved mechanical properties (Figure 1(c)).
Hydrogels containing only 20% (v/v) of glycerol had
a 40-fold increase in their young’s modulus after 72 h of
drying. The change in hydrogel’s young modulus was
about fourfold and threefold when the glycerol concen-
tration was 40% and 60%, respectively. This
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demonstrates the plasticizing effect of glycerol leading
to the fabrication of durable flexible patches that retain
their flexibility even after 27 h at 37C (Figure 1(d)) in
contrast to commercial patches which become fragile
after only 10 h.
A pre-requisite of hydrogel material to be used for
wound dressing purposes is the ability of managing the
excessive wound exudate, particularly typical of chron-
ic wounds. Following BS EN 13726 standard (British
Standards Institution, “Test methods for primary wound
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dressings. Aspects of absorbency”),41 we assessed the
water uptake and degradation rate of alginate hydro-
gels (10 10mm, n¼ 6) with different concentrations
of glycerol in 2mL of aqueous solution of Naþ
(142mmol) and Ca2þ (2.5mmol) with an ionic compo-
sition similar to human serum and wound exudate, as
suggested by the standard. The results shown in
Figure 2(a) indicate that after 3 h the samples absorbed
exudate-mimicking solution to different extents, with
the alginate sample exhibiting the highest absorption
(around 100% increase in weight) and glycerol-
containing samples with 45%–80% increase in
weight. The liquid uptake capacity decreased for
hydrogels containing higher concentrations of glycerol.
This is probably caused by higher concentrations of
glycerol rendering alginate-based hydrogels water
impermeable, leading to a lower exudate uptake.
We also evaluated the effect of glycerol on the dehy-
dration rate of hydrogels (Figure 2(b)). Results showed
a more gradual dehydration rate for glycerol-
containing hydrogels in comparison to pristine algi-
nate. Pristine alginate samples lost around 90% of
their weight in less than 20 h, while glycerol-
containing samples lost between 80 and 60% after
20 h of dehydration. The final remaining weight of
the alginate glycerol samples was approximately 18%,
28% and 44% (for 20%, 40% and 60% v/v of glycerol,
respectively), which were lower than the nominal
values. We speculated that when glycerol concentration
increases, the alginate network was not able to embed
such amount of plasticizer and probably some was lost
during the fabrication process.
Another important characteristic of wound patches
is their gas permeability, especially to oxygen, since its
delivery to the wound area has a key role in promoting
the healing process.42 Oxygen permeability of alginate
samples with different concentrations of glycerol was
assessed using a custom-built chamber (Figure 2(c)).
Briefly, at one side the air-tight chamber had an inlet
for nitrogen gas, an outlet valve and a plug for the
oxygen probe. On the other side, samples were placed
on a circular window, which allowed gas permeation
only through the samples (Figure 2(c)). First, nitrogen
was purged into the chamber, with the outlet valve
opened, until all the oxygen was completely removed
from inside. Then, the nitrogen flow was stopped and
the oxygen concentration inside the chamber was mon-
itored over time. The proper sealing of the platform
was tested by placing an impermeable rubber and
observing no significant change in oxygen concentra-
tion over time. Alginate samples were also compared to
a commercially available alginate-based hydrogel and a
PDMS sheet, which is known to be a gas-permeable
polymer used for engineering breathable bioreactors
used in cell culture.43 Results showed no significant
variation among alginate-based samples (p< 0.05)
(Figure 2(d)), leading to the conclusion that the tested
materials had suitable gas permeability.
The biocompatibility of fabricated hydrogels was
evaluated by culturing alginate hydrogels containing
different concentrations of glycerol with human
immortalized keratinocytes, the predominant cell line
in epidermis. Cells were cultured at the bottom of
multi-well plates and samples were placed in cell cul-
ture inserts (8.0 mm pore). The metabolic activity of
the cells was evaluated over the course of seven
days as indicator of cell proliferation and viability
(Figure 2(e)). Results suggested no significant variation
in cellular activity due to the different concentration of
glycerol and confirmed hydrogel biocompatibility even
with high concentrations of glycerol.
Recently, engineering of wound patches with anti-
oxidant compounds has attracted a great interest as
they can modulate immune system response and can
also offer antibacterial activity.44 Curcumin is a deriv-
ative of o-methoxyphenol and possesses high free-
radical scavenging, anti-inflammatory and anti-
bacterial properties.45–47 Resveratrol is a natural poly-
phenolic compound derived from grapes which also
exhibits anti-bacterial properties and has shown to
enhance tissue regeneration in diabetic rats.37,48–50
Considering the high potential of antioxidant agents
in modulating different aspects of the healing process,
we added two antioxidant compounds, i.e. curcumin
and t-resveratrol, to the alginate hydrogel. The compo-
sition of 2% (w/v) alginate with 20% (v/v) of glycerol
was selected for these experiments due to its overall
better characteristics. We added t-resveratrol and cur-
cumin to the hydrogel matrix separately, both as etha-
nolic solutions, to achieve two different concentrations
(150 and 300 lg/mL, respectively). Concentrations of t-
resveratrol and curcumin were chosen according to the
data available in the literature, based on the minimum
concentration that was reported to be potent against
bacteria.36,37 First, we investigated the influence of the
active compounds on the mechanical properties of the
alginate hydrogel (Figure 3(a)). The obtained data
showed a slight increase in the ultimate tensile strength
for the sample containing 300 lg/mL of curcumin,
while there was no significant difference between the
samples and the hydrogel without the antioxidants.
Thus, it was concluded that the suitable mechanical
properties of the hydrogels were preserved after addi-
tion of the antioxidant solutions to the alginate. It is
likely that the slight change observed in mechanical
properties might be attributed to the ethanol rather
than to the antioxidant compounds.
The engineered alginate patch was used to provide
controlled release of antioxidants in order to modulate
the function of immune system and prevent hyper-
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inflammation and prevent bacterial growth. Thus, we
initially evaluated the release of antioxidants through
the hydrogel patch using FITC-dextran over 72 h,
which is a standard molecule used to assess the release
of active compounds (Figure S3). The majority of the
encapsulated FITC-dextran was released within the
first 24 h. To assess the release rate of active com-
pounds from the hydrogel patches and to mimic the
topical application of the patch, we formed an ALI
(Figure 3(b)). In fact, the release using the ALI
occurs only through one surface that will eventually
be in contact with skin, thus it better simulates the
final application of the engineered topical wound
patch. Cumulative release of t-resveratrol and curcu-
min were evaluated at 37C over the course of 72 h
(Figure 3(c and d)) using the ALI configuration. For
t-resveratrol, the results indicated an initial burst
release, after which the mechanism of release was gov-
erned by diffusion. After 72 h, cumulative release of
55% and 42% were measured for samples loaded
with 150 and 300 lg/mL of t-resveratrol, respectively.
Regarding curcumin, the obtained data showed a
smaller burst release compared to t-resveratrol.
Cumulative release reached 73% and 37% after 72 h
for samples with 150 and 300 lg/mL of curcumin,
respectively. Both the release profiles presented a shift
between samples with lower and higher concentration
of the drug. It is worth to notice that both the releases
are expressed as percentage of cumulative release.
Thus, even though the profiles of the samples with
higher concentrations of drugs are lower, the actual
amounts of released drugs are higher. In fact, 8.1
and 12.3 lg were released from samples with 150
and 300 lg/mL of t-resveratrol, respectively, while the
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same amount of curcumin (10.8 and 10.8 lg) was
released from samples with 150 and 300 lg/mL of cur-
cumin, respectively. The maximum release of curcumin
from the sample was reached after 72 h. This could be
attributed to the lower water solubility of curcumin
(3.12mg/L) compared to t-resveratrol (30mg/L).
Based on the release data, we also evaluated the
amount of drug released per cm2 of skin. We obtained
a release of 25.0 and 40.0 lg/cm2 for samples with 150
and 300 lg/mL of t-resveratrol, respectively.
Approximately, 33.3 lg/cm2 were released for both
curcumin-loaded samples.
To confirm the biocompatibility of the hydrogel
patch, hydrogel samples with t-resveratrol and curcu-
min were cultured with human keratinocytes for seven
days and cell metabolic activity was assessed by
PrestoBlue assay (Figure 4(a)). Results suggested no
negative effect on cell growth, except for the sample
with higher concentration of curcumin. In this case,
cells did not grow during the considered time,
suggesting a possible toxicity of curcumin at that
level. This is in agreement with the previous observa-
tions of Lundvig et al.,51 who reported a caspase-
dependent apoptosis in HaCaT cells induced by curcu-
min in a dose-dependent manner. However, hydrogel
with 150 lg/mL of t-resveratrol seemed to improve cell
growth, compared to the control samples. After seven
days of culture, cells were stained with F-actin and
DAPI and no visible changes were noticed on cell mor-
phology (Figure 4(b)).
Finally, antimicrobial activity of the drug-embedded
hydrogels was assessed against S. aureus, which is a
Gram-positive bacteria and part of the typical skin
flora. A qualitative analysis of antibacterial properties
of hydrogels was assessed by disk diffusion method.
Disks of hydrogel with different concentrations of t-
resveratrol and curcumin were placed on an agar
plate where bacteria were previously inoculated, and
incubated for 24 h. After that time, formation of a
circular ring around the sample, called inhibition
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Figure 4. Biocompatibility and antimicrobial activity of the drug-embedded hydrogels. (a) Cell metabolic activity of keratinocytes
exposed to hydrogels with different concentrations of drugs. (b) Fluorescent micrographs of F-actin (green) and DAPI (blue) staining
of keratinocytes (i) control (i) and cultured with 150 lg/mL of t-resveratrol (ii) and curcumin (iii). (c) Evaluation of antimicrobial
activity against Staphylococcus aureus by disk diffusion test of alginate 2% with 20% of glycerol (i) and hydrogel with 150 lg/mL of
tresveratrol (ii), 300 lg/mL of t-resveratrol (iii), 150 lg/mL of curcumin (iv) and 300 lg/mL of curcumin (Scale bar: 100 lm).
(**p< 0.01 and ****p< 0.0001).
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zone, attested the activity of the released compound
against the bacteria, which are not able to grow or
were killed. Results indicated that all the evaluated
hydrogels were active against the considered bacteria,
while the control (2% w/v alginate with 20% v/v glyc-
erol) did not show any activity against the microbial
growth (Figure 4(c)).
To assess the effectiveness of the alginate-based
dressings and the released compounds in healing of
skin cuts, a conventional scratch assay was conducted
in which an approximately 100-mm wide scratch was
created in a confluent monolayer of keratinocytes
(Figure 5). The dressings were placed on top of cell
culture inserts at the ALI to release the loaded drugs
into the culture media. We assessed the scratch closure
after 24 h and the results suggested that only samples
containing 300 lg/mL of t-resveratrol showed a faster
closure in comparison to the negative control. On the
other hand, 150 lg/mL of curcumin showed a faster
scratch closure. Overall, the results suggested that cur-
cumin offers a higher bacteriostatic effect as well as
stimulatory effect for cellular growth. Combined with
the well-documented anti-inflammatory effects of cur-
cumin, we believe that alginate dressings containing
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Figure 5. Evaluating the wound-healing properties of drug-embedded hydrogels. (a) Scratch assays carried out over samples in
contact with hydrogels loaded with different concentrations of drugs. (b) Evaluating the scratch coverage percentage after 24 h
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curcumin can be an excellent dressing for treatment of
skin disorders. However, this yet remains to be evalu-
ated in vivo using future animal studies.
Conclusions
We fabricated an alginate-based hydrogel with embed-
ded biologically active compounds. The developed
hydrogel patch is breathable and able to maintain
excellent mechanical properties over time (at least
72 h). Two antioxidants including curcumin and
t-resveratrol were separately encapsulated within the
alginate-based hydrogel and their release rate was eval-
uated. The results suggested a burst release followed by
a gradual release of active compounds. The hydrogel
was biocompatible and the antioxidants containing
curcumin up to 150 lg/mL and t-resveratrol up to
300 lg/mL did not induce any toxicity to human kera-
tinocytes. The patch containing curcumin was more
potent against bacterial growth. The engineered wet
wound dressings can be used for the treatment of
many skin disorders as they can both modulate
immune response and control bacterial growth.
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